Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Drugs in Context|January 17, 2014
Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questionsJames S KalusAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 23, 2010
Pharmacotherapeutic decision-making for patients with atrial fibrillationJames S KalusJournal of Managed Care Pharmacy : JMCP|August 15, 2009
Pharmacologic management of atrial fibrillation: established and emerging optionsJames S KalusAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 4, 2013
Pharmacologic interventions for reversing the effects of oral anticoagulantsJames S KalusAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 27, 2018
Overview of betrixaban and its role in clinical practiceJona Lekura, James S KalusPharmacotherapy|August 12, 2004
Magnesium for the treatment and prevention of atrial tachyarrhythmiasAlexandria A Piotrowski, James S KalusThe Annals of Pharmacotherapy|October 26, 2002
Amlodipine versus Angiotensin-receptor blockers for nonhypertension indicationsJames S Kalus, C Michael WhiteExpert Opinion on Investigational Drugs|May 25, 2004
Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudinJames S Kalus, Michael F CaronThe Annals of Pharmacotherapy|November 13, 2004
Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromesLynette R Moser, James S KalusJournal of Clinical Pharmacology|January 19, 2010
Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysisDouglas L Jennings, James S KalusPageof 6